Mark J. Foley, CEO: Revance Therapeutics RVNC Sell · Filed 23/06/13

Trade details

Type: Insider sale
Amount: $960,890.88
Shares · price: 31,279 sh · $30.72 a share
Held after: 891,933 sh
Stock: Revance Therapeutics RVNC
Person: Mark J. FoleyCEO
Trade date: 23/06/09
Filed: 23/06/13
Days to filing: 4 days

Sold 3.4% of holdings

Share of holding sold: 3.4%

Revance Therapeutics trades, last 26 weeks

What else happened in Revance Therapeutics around then

Filed or reported within 30 days of the trade day · 23/05/10~23/07/09

Mark J. Foley's recent trades

Mark J. FoleyDirector
SellGlaukos
Sell
Glaukos
GKOS
$2.5M
20,687 sh
$2.5M
Filed 25/02/28
Traded 25/02/26
Mark J. FoleyDirector
Planned saleGlaukos
Planned sale
Glaukos
GKOS
$2.5M
20,687 sh
$2.5M
Filed 25/02/26
Traded 25/02/26
Mark J. FoleyCEO
BuyRevance Therapeutics
Buy
Revance Therapeutics
RVNC
$209.4K
30,000 sh
$209.4K
Filed 24/03/08
Traded 24/03/06
Mark J. FoleyDirector
SellGlaukos
Sell
Glaukos
GKOS
$423.5K
4,560 sh
$423.5K
Filed 24/02/26
Traded 24/02/23
Mark J. FoleyCEO
Sell10b5-1 planRevance Therapeutics
Sell10b5-1 plan
Revance Therapeutics
RVNC
$593.1K
26,279 sh
$593.1K
Filed 23/08/04
Traded 23/08/03